TerrAscend (TSNDF) Free Cash Flow (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Free Cash Flow of $7.6 million for Q1 2026, down 13.58% year-over-year from $8.8 million in Q1 2025, and down 59.23% quarter-over-quarter from $18.7 million in Q4 2025.
TerrAscend (TSNDF) Free Cash Flow (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Free Cash Flow for 6 consecutive years, with $7.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 13.58% year-over-year to $7.6 million; the TTM figure through Mar 2026 stood at $24.1 million (down 36.06% YoY), while the FY2025 annual figure was $25.3 million, down 35.67% from the prior year.
- Free Cash Flow slipped to $7.6 million in Q1 2026 per TSNDF's latest filing, from $18.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $18.8 million in Q2 2024 and bottomed at -$27.3 million in Q2 2022.
- Historically, Free Cash Flow has averaged $2.0 million across 5 years, with a median of $5.8 million in 2023.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 702.24% — and 2023, when it soared 739.79%.
- TerrAscend's Free Cash Flow stood at -$15.9 million in 2022, then jumped by 111.46% to $1.8 million in 2023, then soared by 121.33% to $4.0 million in 2024, then jumped by 363.12% to $18.7 million in 2025, then sank by 59.23% to $7.6 million in 2026.
- Business Quant data shows TSNDF's Free Cash Flow at $7.6 million in Q1 2026, $18.7 million in Q4 2025, and $445000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | 5.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.75 Mn |
| Jun 30, 2026 | 5.75 Mn |
| Mar 31, 2026 | 7.62 Mn |
| Mar 31, 2026 | 7.62 Mn |
| Dec 31, 2025 | 18.70 Mn |
| Dec 31, 2025 | 18.70 Mn |
| Sep 30, 2025 | 445,000.00 |
| Sep 30, 2025 | 445,000.00 |
| Jun 30, 2025 | -2.65 Mn |
| Jun 30, 2025 | -2.65 Mn |
| Mar 31, 2025 | 8.82 Mn |
| Mar 31, 2025 | 8.82 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 18.77 Mn |
| Jun 30, 2024 | 18.77 Mn |
| Mar 31, 2024 | 10.46 Mn |
| Mar 31, 2024 | 10.46 Mn |